Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Acute Renal Failure Trial Network (ATN) Study

ClinicalTrials.gov ID: NCT00076219

Public ClinicalTrials.gov record NCT00076219. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 7:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CSP #530 - Intensive vs. Conventional Renal Support in Acute Renal Failure

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center, prospective, randomized, parallel-group trial of an intensive strategy vs conventional strategy of renal replacement therapy for the treatment of acute renal failure secondary to acute tubular necrosis in critically ill patients. The primary hypothesis is that the intensive strategy will reduce 60-day all cause mortality by 10% compared to the conventional strategy - i.e.,a reduction from 55% in the conventional arm to 45% in the intensive arm. Secondary outcomes are 60-day in-hospital all-cause mortality, 1-year all cause mortality, and recovery of renal function by day 28. The study will recruit 1164 patients over a period of 3 years, 8 months and each patient will be actively followed for 60 days.

Study identification

NCT ID
NCT00076219
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,124 participants

Conditions and interventions

Interventions

Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2003 (Type not available)
Primary completion
Sep 2007 (Actual)
Completion
Jul 2008 (Actual)
Last update posted
Aug 23, 2013

2003 – 2008

United States locations

U.S. sites
22
U.S. states
20
U.S. cities
22
Facility City State ZIP Site status
Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock No. Little Rock Arkansas 72114-1706 —
VA Medical Center, San Francisco San Francisco California 94121 —
VA Greater Los Angeles Healthcare System, West LA West Los Angeles California 90073 —
VA Eastern Colorado Health Care System, Denver Denver Colorado 80220 —
VA Connecticut Health Care System (West Haven) West Haven Connecticut 06516 —
VA Medical Center, Miami Miami Florida 33125 —
VA Medical Center, Augusta Augusta Georgia 30904 —
Richard Roudebush VA Medical Center, Indianapolis Indianapolis Indiana 46202-2884 —
VA Maryland Health Care System, Baltimore Baltimore Maryland 21201 —
VA Medical Center, Jamaica Plain Campus Boston Massachusetts 02130 —
VA Ann Arbor Healthcare System Ann Arbor Michigan 48113 —
VA Medical Center, St Louis St Louis Missouri 63106 —
VA Western New York Healthcare System at Buffalo Buffalo New York 14215 —
Wake Forest University School of Medicine Winston-Salem North Carolina 27157-1053 —
VA Medical Center, Cleveland Cleveland Ohio 44106 —
VA Medical Center, Portland Portland Oregon 97201 —
VA Pittsburgh Health Care System Pittsburgh Pennsylvania 15240 —
VA Medical Center Nashville Tennessee 37212-2637 —
VA North Texas Health Care System, Dallas Dallas Texas 75216 —
Michael E. DeBakey VA Medical Center (152) Houston Texas 77030 —
Hunter Holmes McGuire VA Medical Center Richmond Virginia 23249 —
VA Puget Sound Health Care System, Seattle Seattle Washington 98108 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00076219, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 23, 2013 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00076219 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →